Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).

For patients transitioning from rituximab to ravulizumab, meningococcal vaccination can be safely done within 6 months after stopping rituximab.

March 4 is International Human Papillomavirus (HPV) Awareness Day. The New York State Department of Health is stressing the ...

The latest meeting of the US CDC Advisory Committee on Immunization Practices has been postponed indefinitely to allow time for public comments to be collected.

The FDA canceled a meeting of vaccine advisors scheduled for next month to decide the composition of next season's influenza ...

HHS Secretary Robert F. Kennedy Jr. appears to be planning major changes to the way his department oversees vaccines, media ...

Latest data shows significant rise in parents sending kindergarteners to school without the required measles vaccine.

Immunization rates have dipped low enough in some communities that measles has taken root and spread. For the first time in a decade, someone in the U.S. has died from ...